

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.51858922 |
| 2 | DNA double-strand break processing (GO:0000729) | 4.92419604 |
| 3 | DNA deamination (GO:0045006) | 4.91139801 |
| 4 | cullin deneddylation (GO:0010388) | 4.54230141 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28998726 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28998726 |
| 7 | protein deneddylation (GO:0000338) | 4.12238728 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10969748 |
| 9 | synapsis (GO:0007129) | 4.09298844 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04058866 |
| 11 | lactate metabolic process (GO:0006089) | 4.00466484 |
| 12 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.98615415 |
| 13 | leukocyte aggregation (GO:0070486) | 3.98501287 |
| 14 | replication fork processing (GO:0031297) | 3.94289011 |
| 15 | protein K6-linked ubiquitination (GO:0085020) | 3.89746108 |
| 16 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.83286972 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.81325129 |
| 18 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.77994800 |
| 19 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.77994800 |
| 20 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.77994800 |
| 21 | platelet dense granule organization (GO:0060155) | 3.75174362 |
| 22 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.75102821 |
| 23 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.75102821 |
| 24 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.74767179 |
| 25 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.74059137 |
| 26 | regulation of DNA endoreduplication (GO:0032875) | 3.73212946 |
| 27 | respiratory chain complex IV assembly (GO:0008535) | 3.72889075 |
| 28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.72616888 |
| 29 | positive regulation of protein autophosphorylation (GO:0031954) | 3.68608723 |
| 30 | chromatin remodeling at centromere (GO:0031055) | 3.66451370 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65717093 |
| 32 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.61654828 |
| 33 | isotype switching (GO:0045190) | 3.61654828 |
| 34 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.61654828 |
| 35 | CENP-A containing nucleosome assembly (GO:0034080) | 3.59876937 |
| 36 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.56446732 |
| 37 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.56446732 |
| 38 | negative regulation of phagocytosis (GO:0050765) | 3.56049894 |
| 39 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.55548548 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.55009249 |
| 41 | histone exchange (GO:0043486) | 3.54012818 |
| 42 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.53788525 |
| 43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.45133136 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41792602 |
| 45 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.40724653 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.35803359 |
| 47 | signal peptide processing (GO:0006465) | 3.33804016 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32927548 |
| 49 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.32711338 |
| 50 | negative regulation of ligase activity (GO:0051352) | 3.29264730 |
| 51 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.29264730 |
| 52 | keratinocyte development (GO:0003334) | 3.24355641 |
| 53 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.23310976 |
| 54 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.22734872 |
| 55 | cytochrome complex assembly (GO:0017004) | 3.21659736 |
| 56 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.19575529 |
| 57 | recombinational repair (GO:0000725) | 3.18437859 |
| 58 | double-strand break repair via homologous recombination (GO:0000724) | 3.18238126 |
| 59 | ribosomal small subunit assembly (GO:0000028) | 3.16666888 |
| 60 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16121559 |
| 61 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.13461898 |
| 62 | positive regulation of ligase activity (GO:0051351) | 3.11651045 |
| 63 | interferon-gamma production (GO:0032609) | 3.10133262 |
| 64 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.08604512 |
| 65 | DNA strand elongation (GO:0022616) | 3.08560076 |
| 66 | prenylation (GO:0097354) | 3.08127198 |
| 67 | protein prenylation (GO:0018342) | 3.08127198 |
| 68 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.08058359 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 3.06505285 |
| 70 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.05457067 |
| 71 | cellular response to zinc ion (GO:0071294) | 3.03183342 |
| 72 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.02099251 |
| 73 | non-recombinational repair (GO:0000726) | 3.01735389 |
| 74 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.01735389 |
| 75 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.00592508 |
| 76 | negative T cell selection (GO:0043383) | 2.97695296 |
| 77 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.96990152 |
| 78 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.96987768 |
| 79 | rRNA methylation (GO:0031167) | 2.96345745 |
| 80 | resolution of meiotic recombination intermediates (GO:0000712) | 2.94757137 |
| 81 | negative thymic T cell selection (GO:0045060) | 2.93136744 |
| 82 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.92058877 |
| 83 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.92058877 |
| 84 | DNA unwinding involved in DNA replication (GO:0006268) | 2.90974990 |
| 85 | maturation of 5.8S rRNA (GO:0000460) | 2.90727063 |
| 86 | positive regulation of cell cycle arrest (GO:0071158) | 2.90148438 |
| 87 | defense response to protozoan (GO:0042832) | 2.89567925 |
| 88 | telomere maintenance via recombination (GO:0000722) | 2.89180231 |
| 89 | histone mRNA catabolic process (GO:0071044) | 2.89169257 |
| 90 | regulation of meiosis I (GO:0060631) | 2.88890805 |
| 91 | histone mRNA metabolic process (GO:0008334) | 2.87791441 |
| 92 | female gonad development (GO:0008585) | 2.86806210 |
| 93 | T cell migration (GO:0072678) | 2.86005201 |
| 94 | response to X-ray (GO:0010165) | 2.85035831 |
| 95 | response to protozoan (GO:0001562) | 2.84573752 |
| 96 | response to pheromone (GO:0019236) | 2.84509495 |
| 97 | rRNA modification (GO:0000154) | 2.83865896 |
| 98 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.83699159 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 2.82369288 |
| 100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.82252774 |
| 101 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.82048791 |
| 102 | regulation of B cell differentiation (GO:0045577) | 2.80919053 |
| 103 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.80202219 |
| 104 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.80202219 |
| 105 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.79639989 |
| 106 | ribosome assembly (GO:0042255) | 2.79528044 |
| 107 | respiratory burst (GO:0045730) | 2.79449637 |
| 108 | mitochondrial DNA replication (GO:0006264) | 2.79314610 |
| 109 | B cell mediated immunity (GO:0019724) | 2.78246736 |
| 110 | actin nucleation (GO:0045010) | 2.77947602 |
| 111 | postreplication repair (GO:0006301) | 2.76478230 |
| 112 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.76338521 |
| 113 | regulation of ligase activity (GO:0051340) | 2.75633789 |
| 114 | cytidine deamination (GO:0009972) | 2.75369349 |
| 115 | cytidine metabolic process (GO:0046087) | 2.75369349 |
| 116 | cytidine catabolic process (GO:0006216) | 2.75369349 |
| 117 | spindle checkpoint (GO:0031577) | 2.74459003 |
| 118 | mitotic recombination (GO:0006312) | 2.73778814 |
| 119 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.73753856 |
| 120 | myeloid dendritic cell activation (GO:0001773) | 2.72952629 |
| 121 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.72265491 |
| 122 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.72265491 |
| 123 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.72265491 |
| 124 | B cell receptor signaling pathway (GO:0050853) | 2.70937085 |
| 125 | positive regulation of isotype switching (GO:0045830) | 2.70776039 |
| 126 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.70096599 |
| 127 | branched-chain amino acid catabolic process (GO:0009083) | 2.66461459 |
| 128 | protein localization to kinetochore (GO:0034501) | 2.66263048 |
| 129 | cellular extravasation (GO:0045123) | 2.66142849 |
| 130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65778148 |
| 131 | regulation of protein autophosphorylation (GO:0031952) | 2.65002913 |
| 132 | positive regulation of interferon-alpha production (GO:0032727) | 2.63968298 |
| 133 | double-strand break repair (GO:0006302) | 2.63594642 |
| 134 | histone H2A acetylation (GO:0043968) | 2.62753217 |
| 135 | regulation of Rac protein signal transduction (GO:0035020) | 2.62682420 |
| 136 | sequestering of actin monomers (GO:0042989) | 2.62381519 |
| 137 | protein neddylation (GO:0045116) | 2.61607500 |
| 138 | purine nucleobase biosynthetic process (GO:0009113) | 2.61557114 |
| 139 | neutrophil activation (GO:0042119) | 2.60870925 |
| 140 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58999031 |
| 141 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57186029 |
| 142 | mitotic chromosome condensation (GO:0007076) | 2.57019253 |
| 143 | regulation of response to interferon-gamma (GO:0060330) | 2.56862632 |
| 144 | DNA replication initiation (GO:0006270) | 2.56240082 |
| 145 | NIK/NF-kappaB signaling (GO:0038061) | 2.54548092 |
| 146 | regulation of interferon-alpha production (GO:0032647) | 2.54130273 |
| 147 | mast cell activation (GO:0045576) | 2.54074449 |
| 148 | hepatocyte apoptotic process (GO:0097284) | 2.53325471 |
| 149 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52617613 |
| 150 | response to peptidoglycan (GO:0032494) | 2.52168081 |
| 151 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51195125 |
| 152 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51195125 |
| 153 | modulation by symbiont of host immune response (GO:0052553) | 2.51195125 |
| 154 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51195125 |
| 155 | modulation by symbiont of host defense response (GO:0052031) | 2.51195125 |
| 156 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51195125 |
| 157 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.50446257 |
| 158 | cellular response to interferon-beta (GO:0035458) | 2.49086514 |
| 159 | negative regulation of growth of symbiont in host (GO:0044130) | 2.49086182 |
| 160 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.49086182 |
| 161 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.49086182 |
| 162 | regulation of growth of symbiont in host (GO:0044126) | 2.49086182 |
| 163 | positive thymic T cell selection (GO:0045059) | 2.48633049 |
| 164 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.47774278 |
| 165 | leukocyte cell-cell adhesion (GO:0007159) | 2.47639005 |
| 166 | pinocytosis (GO:0006907) | 2.47562155 |
| 167 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43074998 |
| 168 | response to type I interferon (GO:0034340) | 2.42642110 |
| 169 | kinetochore organization (GO:0051383) | 2.42326896 |
| 170 | cellular response to type I interferon (GO:0071357) | 2.41608535 |
| 171 | type I interferon signaling pathway (GO:0060337) | 2.41608535 |
| 172 | granulocyte activation (GO:0036230) | 2.41460088 |
| 173 | positive regulation of macrophage differentiation (GO:0045651) | 2.39941396 |
| 174 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.39730120 |
| 175 | natural killer cell mediated immunity (GO:0002228) | 2.39730120 |
| 176 | protein localization to chromosome, centromeric region (GO:0071459) | 2.39702906 |
| 177 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.37988347 |
| 178 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.37670160 |
| 179 | response to interleukin-15 (GO:0070672) | 2.37492136 |
| 180 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.37403997 |
| 181 | mitotic nuclear envelope disassembly (GO:0007077) | 2.35979355 |
| 182 | neutrophil mediated immunity (GO:0002446) | 2.32883729 |
| 183 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.32826334 |
| 184 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32277629 |
| 185 | leukocyte mediated cytotoxicity (GO:0001909) | 2.30733252 |
| 186 | cellular response to interleukin-15 (GO:0071350) | 2.29976423 |
| 187 | formation of translation preinitiation complex (GO:0001731) | 2.29205602 |
| 188 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.29183801 |
| 189 | telomere maintenance via telomere lengthening (GO:0010833) | 2.28375517 |
| 190 | establishment of chromosome localization (GO:0051303) | 2.27320250 |
| 191 | T cell homeostasis (GO:0043029) | 2.26290754 |
| 192 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.25779100 |
| 193 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.25621702 |
| 194 | regulation of necroptotic process (GO:0060544) | 2.25484056 |
| 195 | nuclear pore complex assembly (GO:0051292) | 2.25448228 |
| 196 | myeloid dendritic cell differentiation (GO:0043011) | 2.25178128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.57225920 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.89257915 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59013766 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42554085 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.24587249 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.15161506 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07217809 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.02150867 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.92825559 |
| 10 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.90725940 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78299489 |
| 12 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.67324067 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65989828 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64898506 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.56039922 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.50002841 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49946964 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.47572162 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.40289040 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.40176796 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.38285899 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30432486 |
| 23 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27058427 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.21312423 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.13517074 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 2.13081038 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.11881000 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.11724880 |
| 29 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11187549 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.08902336 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03919597 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 2.02708183 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.01108826 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00976152 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00147183 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99861940 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.96098958 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93989925 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93905938 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92872606 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89253812 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.88054241 |
| 43 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.87455917 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87029847 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.85146623 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83603384 |
| 47 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.82134678 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81981366 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.81133285 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.75483639 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.75310523 |
| 52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72762570 |
| 53 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.72266608 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.72263863 |
| 55 | * MAF_26560356_Chip-Seq_TH1_Human | 1.67274232 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66554941 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.66461290 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66311582 |
| 59 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62419547 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.61282754 |
| 61 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.60410315 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59770211 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57902394 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.57550006 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57010212 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55993576 |
| 67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.53833252 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53572856 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52609097 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50771018 |
| 71 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.49831457 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49589725 |
| 73 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49295891 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49058085 |
| 75 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.48723948 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47643602 |
| 77 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47420750 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46262960 |
| 79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.46078487 |
| 80 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.45915082 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43778163 |
| 82 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43580431 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39520284 |
| 84 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.38320996 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36991755 |
| 86 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36605862 |
| 87 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36159575 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35670995 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34472090 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33772693 |
| 91 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33207562 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33144749 |
| 93 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31322911 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.30644728 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30419494 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29760888 |
| 97 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27102146 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27028899 |
| 99 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25393337 |
| 100 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25393337 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25247148 |
| 102 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23691246 |
| 103 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20038237 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19781001 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19494891 |
| 106 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.18977723 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18768729 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18762177 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18669733 |
| 110 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.18017271 |
| 111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17532426 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16945451 |
| 113 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16763246 |
| 114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16021414 |
| 115 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.15454995 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15393809 |
| 117 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15365218 |
| 118 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15287558 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13870814 |
| 120 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13596379 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.13305946 |
| 122 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12103692 |
| 123 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11912183 |
| 124 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11328322 |
| 125 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10601213 |
| 126 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.10582225 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10448000 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09659738 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09050586 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09010918 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07990261 |
| 132 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07288346 |
| 133 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06710726 |
| 134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06076933 |
| 135 | MAF_26560356_Chip-Seq_TH2_Human | 1.06068065 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05784907 |
| 137 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05424521 |
| 138 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05424521 |
| 139 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04405207 |
| 140 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03191185 |
| 141 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02813412 |
| 142 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.02738495 |
| 143 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02309219 |
| 144 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01562611 |
| 145 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01379691 |
| 146 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00975052 |
| 147 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00639025 |
| 148 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00636695 |
| 149 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00636695 |
| 150 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00549414 |
| 151 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00395754 |
| 152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99807319 |
| 153 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99665853 |
| 154 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99558192 |
| 155 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99394552 |
| 156 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98716795 |
| 157 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98615026 |
| 158 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98483225 |
| 159 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97966185 |
| 160 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97866590 |
| 161 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.97444528 |
| 162 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97211228 |
| 163 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97106142 |
| 164 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94506255 |
| 165 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93777912 |
| 166 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93092543 |
| 167 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91946674 |
| 168 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89931446 |
| 169 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89773657 |
| 170 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89740459 |
| 171 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.88307983 |
| 172 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86826797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 4.56403903 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.92300100 |
| 3 | MP0002102_abnormal_ear_morphology | 3.59234702 |
| 4 | MP0005671_abnormal_response_to | 3.11482379 |
| 5 | MP0009785_altered_susceptibility_to | 3.02901783 |
| 6 | MP0003195_calcinosis | 2.95491946 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.82260789 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.72244796 |
| 9 | MP0003436_decreased_susceptibility_to | 2.71347298 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.69159158 |
| 11 | MP0000685_abnormal_immune_system | 2.57632287 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.57402538 |
| 13 | MP0001800_abnormal_humoral_immune | 2.56073729 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.47812062 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.45043703 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.37260334 |
| 17 | MP0005025_abnormal_response_to | 2.36285275 |
| 18 | MP0001819_abnormal_immune_cell | 2.35018499 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.33725645 |
| 20 | MP0009697_abnormal_copulation | 2.32254046 |
| 21 | MP0010094_abnormal_chromosome_stability | 2.30218356 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.28875255 |
| 23 | MP0002419_abnormal_innate_immunity | 2.28795330 |
| 24 | MP0002723_abnormal_immune_serum | 2.28567083 |
| 25 | MP0001790_abnormal_immune_system | 2.27729301 |
| 26 | MP0005387_immune_system_phenotype | 2.27729301 |
| 27 | MP0002398_abnormal_bone_marrow | 2.27215802 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 2.27154472 |
| 29 | MP0005408_hypopigmentation | 2.16894386 |
| 30 | MP0006054_spinal_hemorrhage | 2.15383229 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 2.10355650 |
| 32 | MP0002405_respiratory_system_inflammati | 2.06709872 |
| 33 | MP0008057_abnormal_DNA_replication | 2.03975131 |
| 34 | MP0003077_abnormal_cell_cycle | 2.01084354 |
| 35 | MP0000716_abnormal_immune_system | 1.98273164 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.95183209 |
| 37 | MP0003303_peritoneal_inflammation | 1.93055509 |
| 38 | MP0003724_increased_susceptibility_to | 1.92881235 |
| 39 | MP0003718_maternal_effect | 1.90818351 |
| 40 | MP0002938_white_spotting | 1.90513826 |
| 41 | MP0005171_absent_coat_pigmentation | 1.90023669 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.89619627 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.88521637 |
| 44 | MP0002722_abnormal_immune_system | 1.84793778 |
| 45 | MP0006082_CNS_inflammation | 1.84491271 |
| 46 | MP0001853_heart_inflammation | 1.82521865 |
| 47 | MP0003111_abnormal_nucleus_morphology | 1.81427878 |
| 48 | MP0008007_abnormal_cellular_replicative | 1.77337235 |
| 49 | MP0002429_abnormal_blood_cell | 1.77203035 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.77019342 |
| 51 | MP0002006_tumorigenesis | 1.73845386 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.73484720 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.70496217 |
| 54 | MP0010307_abnormal_tumor_latency | 1.70140215 |
| 55 | MP0004957_abnormal_blastocyst_morpholog | 1.67892977 |
| 56 | MP0000490_abnormal_crypts_of | 1.66691041 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.63617394 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.61740455 |
| 59 | MP0002090_abnormal_vision | 1.61198992 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.61169741 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.61169741 |
| 62 | MP0000858_altered_metastatic_potential | 1.59680084 |
| 63 | MP0000516_abnormal_urinary_system | 1.59607856 |
| 64 | MP0005367_renal/urinary_system_phenotyp | 1.59607856 |
| 65 | MP0002163_abnormal_gland_morphology | 1.58587088 |
| 66 | MP0001873_stomach_inflammation | 1.56957928 |
| 67 | MP0000427_abnormal_hair_cycle | 1.55313022 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.52200948 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.51563263 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.50558797 |
| 71 | MP0003448_altered_tumor_morphology | 1.49192746 |
| 72 | MP0002254_reproductive_system_inflammat | 1.48915491 |
| 73 | MP0008058_abnormal_DNA_repair | 1.45391820 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.44819551 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.42739588 |
| 76 | MP0004947_skin_inflammation | 1.39704173 |
| 77 | MP0005253_abnormal_eye_physiology | 1.34801224 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.28896681 |
| 79 | MP0002019_abnormal_tumor_incidence | 1.28730635 |
| 80 | MP0002933_joint_inflammation | 1.28613351 |
| 81 | MP0000371_diluted_coat_color | 1.23798563 |
| 82 | MP0005395_other_phenotype | 1.21189984 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 1.20475465 |
| 84 | MP0004381_abnormal_hair_follicle | 1.20297106 |
| 85 | MP0009278_abnormal_bone_marrow | 1.19916546 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.18941010 |
| 87 | MP0003866_abnormal_defecation | 1.17046704 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.13204425 |
| 89 | MP0001324_abnormal_eye_pigmentation | 1.11777308 |
| 90 | MP0001119_abnormal_female_reproductive | 1.11399024 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.08370072 |
| 92 | MP0008469_abnormal_protein_level | 1.06629226 |
| 93 | MP0000343_altered_response_to | 1.06273648 |
| 94 | MP0000647_abnormal_sebaceous_gland | 1.04719934 |
| 95 | MP0002282_abnormal_trachea_morphology | 1.03102237 |
| 96 | MP0008872_abnormal_physiological_respon | 1.00602740 |
| 97 | MP0001929_abnormal_gametogenesis | 0.98552353 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.98144445 |
| 99 | MP0000350_abnormal_cell_proliferation | 0.96897199 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.96345325 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.96120875 |
| 102 | MP0000613_abnormal_salivary_gland | 0.96119488 |
| 103 | MP0010678_abnormal_skin_adnexa | 0.95170099 |
| 104 | MP0005023_abnormal_wound_healing | 0.93849402 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.93124899 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.92467306 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.91009005 |
| 108 | MP0000313_abnormal_cell_death | 0.90199704 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90089790 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.89899294 |
| 111 | MP0000358_abnormal_cell_content/ | 0.88987915 |
| 112 | MP0005389_reproductive_system_phenotype | 0.88630413 |
| 113 | MP0003787_abnormal_imprinting | 0.88372059 |
| 114 | MP0008932_abnormal_embryonic_tissue | 0.87404189 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.85295139 |
| 116 | MP0002168_other_aberrant_phenotype | 0.84661498 |
| 117 | MP0001730_embryonic_growth_arrest | 0.84093407 |
| 118 | MP0000653_abnormal_sex_gland | 0.84077928 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.82932984 |
| 120 | MP0004484_altered_response_of | 0.82462794 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.82138557 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.81671881 |
| 123 | MP0009764_decreased_sensitivity_to | 0.80902978 |
| 124 | MP0003828_pulmonary_edema | 0.79301326 |
| 125 | MP0005310_abnormal_salivary_gland | 0.78855412 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.78750583 |
| 127 | MP0002095_abnormal_skin_pigmentation | 0.77329487 |
| 128 | MP0002210_abnormal_sex_determination | 0.77188186 |
| 129 | MP0002132_abnormal_respiratory_system | 0.76347521 |
| 130 | MP0008995_early_reproductive_senescence | 0.76336212 |
| 131 | MP0004510_myositis | 0.75893237 |
| 132 | MP0003252_abnormal_bile_duct | 0.75798916 |
| 133 | MP0003786_premature_aging | 0.74858499 |
| 134 | MP0003186_abnormal_redox_activity | 0.74613180 |
| 135 | MP0005332_abnormal_amino_acid | 0.72887750 |
| 136 | MP0001764_abnormal_homeostasis | 0.72832877 |
| 137 | MP0003890_abnormal_embryonic-extraembry | 0.72366944 |
| 138 | MP0001851_eye_inflammation | 0.72043824 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.71902675 |
| 140 | MP0004147_increased_porphyrin_level | 0.71332845 |
| 141 | MP0001915_intracranial_hemorrhage | 0.71040931 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.70281351 |
| 143 | MP0001697_abnormal_embryo_size | 0.69670382 |
| 144 | MP0005390_skeleton_phenotype | 0.69575238 |
| 145 | MP0001293_anophthalmia | 0.69365783 |
| 146 | MP0008877_abnormal_DNA_methylation | 0.68370060 |
| 147 | MP0002075_abnormal_coat/hair_pigmentati | 0.67589615 |
| 148 | MP0002998_abnormal_bone_remodeling | 0.67209638 |
| 149 | MP0000749_muscle_degeneration | 0.66881779 |
| 150 | MP0001145_abnormal_male_reproductive | 0.66609977 |
| 151 | MP0003646_muscle_fatigue | 0.64483313 |
| 152 | MP0010386_abnormal_urinary_bladder | 0.63812111 |
| 153 | MP0003937_abnormal_limbs/digits/tail_de | 0.63560334 |
| 154 | MP0003941_abnormal_skin_development | 0.62014229 |
| 155 | MP0003795_abnormal_bone_structure | 0.60356730 |
| 156 | MP0002876_abnormal_thyroid_physiology | 0.59785990 |
| 157 | MP0001984_abnormal_olfaction | 0.59551609 |
| 158 | MP0001919_abnormal_reproductive_system | 0.59474557 |
| 159 | MP0003279_aneurysm | 0.58660713 |
| 160 | MP0005187_abnormal_penis_morphology | 0.58566770 |
| 161 | MP0002160_abnormal_reproductive_system | 0.58429862 |
| 162 | MP0001186_pigmentation_phenotype | 0.57843169 |
| 163 | MP0009763_increased_sensitivity_to | 0.57447600 |
| 164 | MP0001661_extended_life_span | 0.57274214 |
| 165 | MP0003656_abnormal_erythrocyte_physiolo | 0.56848422 |
| 166 | MP0000249_abnormal_blood_vessel | 0.56802047 |
| 167 | MP0005645_abnormal_hypothalamus_physiol | 0.56550669 |
| 168 | MP0001663_abnormal_digestive_system | 0.55789995 |
| 169 | MP0004782_abnormal_surfactant_physiolog | 0.55510812 |
| 170 | MP0002080_prenatal_lethality | 0.53897881 |
| 171 | MP0003984_embryonic_growth_retardation | 0.53427681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.76002733 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.47668381 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12174249 |
| 4 | Myositis (HP:0100614) | 3.99379450 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.96753484 |
| 6 | Thrombocytosis (HP:0001894) | 3.83864242 |
| 7 | Recurrent viral infections (HP:0004429) | 3.61615371 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.57713845 |
| 9 | T lymphocytopenia (HP:0005403) | 3.57609976 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.55472712 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.48940085 |
| 12 | IgM deficiency (HP:0002850) | 3.48161200 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39040004 |
| 14 | Obstructive lung disease (HP:0006536) | 3.39040004 |
| 15 | Neoplasm of the adrenal cortex (HP:0100641) | 3.31090757 |
| 16 | Chronic otitis media (HP:0000389) | 3.25906346 |
| 17 | Abnormality of T cells (HP:0002843) | 3.23083056 |
| 18 | Abnormality of chromosome stability (HP:0003220) | 3.23051424 |
| 19 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.20931115 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.17299679 |
| 21 | Orchitis (HP:0100796) | 3.07377190 |
| 22 | Meningitis (HP:0001287) | 3.05724629 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.05317509 |
| 24 | Optic neuritis (HP:0100653) | 3.05317509 |
| 25 | Neoplasm of the adrenal gland (HP:0100631) | 3.03592848 |
| 26 | Meckel diverticulum (HP:0002245) | 3.03122957 |
| 27 | Hypothermia (HP:0002045) | 3.02087853 |
| 28 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.00837728 |
| 29 | Progressive macrocephaly (HP:0004481) | 2.97471556 |
| 30 | Abnormality of the ileum (HP:0001549) | 2.94582364 |
| 31 | Eosinophilia (HP:0001880) | 2.93136947 |
| 32 | Cellulitis (HP:0100658) | 2.90978143 |
| 33 | IgG deficiency (HP:0004315) | 2.90357550 |
| 34 | Intestinal atresia (HP:0011100) | 2.89184334 |
| 35 | Increased CSF lactate (HP:0002490) | 2.87701726 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.86381598 |
| 37 | B lymphocytopenia (HP:0010976) | 2.86381598 |
| 38 | Acute necrotizing encephalopathy (HP:0006965) | 2.85317940 |
| 39 | Vasculitis (HP:0002633) | 2.83584076 |
| 40 | Acute encephalopathy (HP:0006846) | 2.83384960 |
| 41 | Petechiae (HP:0000967) | 2.82755316 |
| 42 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.80359299 |
| 43 | Hypoplasia of the fovea (HP:0007750) | 2.80359299 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76594794 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.76348742 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.73968515 |
| 47 | Recurrent skin infections (HP:0001581) | 2.72740381 |
| 48 | Combined immunodeficiency (HP:0005387) | 2.71897511 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.69077899 |
| 50 | Granulocytopenia (HP:0001913) | 2.68863723 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.68546588 |
| 52 | Severe combined immunodeficiency (HP:0004430) | 2.67771273 |
| 53 | Leukocytosis (HP:0001974) | 2.67339042 |
| 54 | Stomatitis (HP:0010280) | 2.65529215 |
| 55 | Abnormality of the preputium (HP:0100587) | 2.64734794 |
| 56 | Small intestinal stenosis (HP:0012848) | 2.64502441 |
| 57 | Duodenal stenosis (HP:0100867) | 2.64502441 |
| 58 | Lymphopenia (HP:0001888) | 2.64130513 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61991556 |
| 60 | Abnormality of eosinophils (HP:0001879) | 2.61336461 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.60583836 |
| 62 | Ependymoma (HP:0002888) | 2.59137438 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.56213958 |
| 64 | Lymphoma (HP:0002665) | 2.54714683 |
| 65 | Volvulus (HP:0002580) | 2.54046802 |
| 66 | Abnormality of the duodenum (HP:0002246) | 2.53957699 |
| 67 | Nasal polyposis (HP:0100582) | 2.53109855 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51375592 |
| 69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51375592 |
| 70 | Pancreatic cysts (HP:0001737) | 2.50558548 |
| 71 | Thyroiditis (HP:0100646) | 2.48502287 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.46959805 |
| 73 | Albinism (HP:0001022) | 2.46733183 |
| 74 | Abnormal lung lobation (HP:0002101) | 2.46608490 |
| 75 | Abnormality of the fovea (HP:0000493) | 2.44872609 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.44455125 |
| 77 | Periodontitis (HP:0000704) | 2.44197670 |
| 78 | Abnormality of the anterior horn cell (HP:0006802) | 2.41011876 |
| 79 | Degeneration of anterior horn cells (HP:0002398) | 2.41011876 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.40999863 |
| 81 | IgA deficiency (HP:0002720) | 2.39726553 |
| 82 | Chronic diarrhea (HP:0002028) | 2.39635244 |
| 83 | Hepatocellular necrosis (HP:0001404) | 2.38265935 |
| 84 | Methylmalonic acidemia (HP:0002912) | 2.36595827 |
| 85 | Recurrent pneumonia (HP:0006532) | 2.36556099 |
| 86 | Clubbing of toes (HP:0100760) | 2.36246066 |
| 87 | Osteomyelitis (HP:0002754) | 2.35736867 |
| 88 | Gingivitis (HP:0000230) | 2.35685316 |
| 89 | Aplastic anemia (HP:0001915) | 2.34919926 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.33396695 |
| 91 | Hypoproteinemia (HP:0003075) | 2.33326870 |
| 92 | Hemoptysis (HP:0002105) | 2.33304895 |
| 93 | Increased hepatocellular lipid droplets (HP:0006565) | 2.32810083 |
| 94 | Breast carcinoma (HP:0003002) | 2.31760089 |
| 95 | Colon cancer (HP:0003003) | 2.30810511 |
| 96 | Agammaglobulinemia (HP:0004432) | 2.29030959 |
| 97 | Congenital stationary night blindness (HP:0007642) | 2.28639759 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.26775078 |
| 99 | Hamartoma of the eye (HP:0010568) | 2.26077136 |
| 100 | Pustule (HP:0200039) | 2.25186047 |
| 101 | Cutaneous melanoma (HP:0012056) | 2.24560641 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.22902869 |
| 103 | Pancreatic fibrosis (HP:0100732) | 2.22272954 |
| 104 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.21711315 |
| 105 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.21099764 |
| 106 | Abnormality of the nasal mucosa (HP:0000433) | 2.20744969 |
| 107 | Agnosia (HP:0010524) | 2.20645361 |
| 108 | Arterial thrombosis (HP:0004420) | 2.19159623 |
| 109 | Pulmonary fibrosis (HP:0002206) | 2.18509476 |
| 110 | Skin ulcer (HP:0200042) | 2.18168073 |
| 111 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.17518321 |
| 112 | Tongue fasciculations (HP:0001308) | 2.16943228 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 2.16894931 |
| 114 | Reticulocytopenia (HP:0001896) | 2.16227570 |
| 115 | Recurrent sinusitis (HP:0011108) | 2.13610321 |
| 116 | Hepatic necrosis (HP:0002605) | 2.13029669 |
| 117 | Keratoconjunctivitis (HP:0001096) | 2.12271667 |
| 118 | Glioma (HP:0009733) | 2.11687640 |
| 119 | Supernumerary spleens (HP:0009799) | 2.11408212 |
| 120 | Encephalitis (HP:0002383) | 2.10162740 |
| 121 | Inflammation of the large intestine (HP:0002037) | 2.09929441 |
| 122 | Cerebral edema (HP:0002181) | 2.08790458 |
| 123 | Conjunctival hamartoma (HP:0100780) | 2.08420874 |
| 124 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07825705 |
| 125 | Gastrointestinal inflammation (HP:0004386) | 2.07268286 |
| 126 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07261044 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06215328 |
| 128 | Increased IgM level (HP:0003496) | 2.05987860 |
| 129 | Amaurosis fugax (HP:0100576) | 2.05059936 |
| 130 | Abnormality of the labia minora (HP:0012880) | 2.04175497 |
| 131 | Abnormality of the astrocytes (HP:0100707) | 2.03143748 |
| 132 | Astrocytoma (HP:0009592) | 2.03143748 |
| 133 | Chest pain (HP:0100749) | 2.02844221 |
| 134 | Autoimmune hemolytic anemia (HP:0001890) | 2.02566968 |
| 135 | Disproportionate short-trunk short stature (HP:0003521) | 2.02304641 |
| 136 | True hermaphroditism (HP:0010459) | 2.01603639 |
| 137 | Chronic sinusitis (HP:0011109) | 2.00893756 |
| 138 | Bronchitis (HP:0012387) | 2.00494764 |
| 139 | Myelodysplasia (HP:0002863) | 2.00257685 |
| 140 | Sloping forehead (HP:0000340) | 1.99833438 |
| 141 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.99603418 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.97431641 |
| 143 | Increased serum lactate (HP:0002151) | 1.97234294 |
| 144 | Abnormality of the pleura (HP:0002103) | 1.96637672 |
| 145 | Abnormality of glycolysis (HP:0004366) | 1.94947609 |
| 146 | Molar tooth sign on MRI (HP:0002419) | 1.93353900 |
| 147 | Abnormality of midbrain morphology (HP:0002418) | 1.93353900 |
| 148 | 11 pairs of ribs (HP:0000878) | 1.93005129 |
| 149 | Gastrointestinal infarctions (HP:0005244) | 1.92634107 |
| 150 | Congenital, generalized hypertrichosis (HP:0004540) | 1.92529796 |
| 151 | Basal ganglia calcification (HP:0002135) | 1.91628125 |
| 152 | Aqueductal stenosis (HP:0002410) | 1.90076406 |
| 153 | Methylmalonic aciduria (HP:0012120) | 1.90035384 |
| 154 | Chromsome breakage (HP:0040012) | 1.89369390 |
| 155 | Sepsis (HP:0100806) | 1.89005456 |
| 156 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88958313 |
| 157 | Prostate neoplasm (HP:0100787) | 1.88793484 |
| 158 | Poikiloderma (HP:0001029) | 1.87760048 |
| 159 | Exertional dyspnea (HP:0002875) | 1.87457983 |
| 160 | Type I transferrin isoform profile (HP:0003642) | 1.87112626 |
| 161 | Birth length less than 3rd percentile (HP:0003561) | 1.86745076 |
| 162 | Small hand (HP:0200055) | 1.86508811 |
| 163 | Dyschromatopsia (HP:0007641) | 1.86421053 |
| 164 | Gastrointestinal stroma tumor (HP:0100723) | 1.85727284 |
| 165 | Papilloma (HP:0012740) | 1.85648405 |
| 166 | Verrucae (HP:0200043) | 1.85648405 |
| 167 | Abnormal platelet volume (HP:0011876) | 1.85270038 |
| 168 | Rhabdomyosarcoma (HP:0002859) | 1.82683847 |
| 169 | Increased serum pyruvate (HP:0003542) | 1.81234723 |
| 170 | Renal Fanconi syndrome (HP:0001994) | 1.78724323 |
| 171 | Abnormality of vitamin B metabolism (HP:0004340) | 1.78339166 |
| 172 | Stillbirth (HP:0003826) | 1.77543668 |
| 173 | Embryonal renal neoplasm (HP:0011794) | 1.75998876 |
| 174 | Muscle fibrillation (HP:0010546) | 1.75702882 |
| 175 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.74089605 |
| 176 | Hematochezia (HP:0002573) | 1.72703830 |
| 177 | Lethargy (HP:0001254) | 1.72548350 |
| 178 | Ovarian neoplasm (HP:0100615) | 1.72357916 |
| 179 | Sensory axonal neuropathy (HP:0003390) | 1.72208159 |
| 180 | Patchy hypopigmentation of hair (HP:0011365) | 1.70142487 |
| 181 | Meningioma (HP:0002858) | 1.68662910 |
| 182 | Iris hypopigmentation (HP:0007730) | 1.67703451 |
| 183 | Respiratory failure (HP:0002878) | 1.67670442 |
| 184 | Neoplasm of the colon (HP:0100273) | 1.67054644 |
| 185 | Bifid tongue (HP:0010297) | 1.66916093 |
| 186 | Median cleft lip (HP:0000161) | 1.66897042 |
| 187 | Abnormal glycosylation (HP:0012345) | 1.66006233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 4.05121332 |
| 2 | MAP4K1 | 3.80880858 |
| 3 | FRK | 3.48314906 |
| 4 | TXK | 3.23785560 |
| 5 | MKNK2 | 2.88209933 |
| 6 | IRAK4 | 2.56494426 |
| 7 | EIF2AK1 | 2.56330011 |
| 8 | BUB1 | 2.27160644 |
| 9 | PLK2 | 2.25355228 |
| 10 | MAP3K14 | 2.25267367 |
| 11 | CDC7 | 2.19738972 |
| 12 | BMPR1B | 2.19375986 |
| 13 | STK10 | 2.17553939 |
| 14 | JAK3 | 2.15562226 |
| 15 | BLK | 2.10528863 |
| 16 | ZAP70 | 1.94345751 |
| 17 | TEC | 1.92855497 |
| 18 | TBK1 | 1.91751501 |
| 19 | TYK2 | 1.90984895 |
| 20 | BCR | 1.87587070 |
| 21 | PIM2 | 1.84861673 |
| 22 | TESK2 | 1.82509547 |
| 23 | BTK | 1.82165320 |
| 24 | WNK3 | 1.79308828 |
| 25 | KIT | 1.77017927 |
| 26 | STK39 | 1.73998983 |
| 27 | VRK2 | 1.64906653 |
| 28 | ITK | 1.61516286 |
| 29 | TESK1 | 1.60556258 |
| 30 | BRSK2 | 1.57892853 |
| 31 | WEE1 | 1.55369023 |
| 32 | CLK1 | 1.52797315 |
| 33 | MAP4K2 | 1.51919955 |
| 34 | NEK2 | 1.50346279 |
| 35 | IKBKE | 1.49605597 |
| 36 | NEK9 | 1.48696920 |
| 37 | TNIK | 1.45008022 |
| 38 | RPS6KA4 | 1.42330776 |
| 39 | SYK | 1.41609988 |
| 40 | OXSR1 | 1.37957650 |
| 41 | TAF1 | 1.37304448 |
| 42 | ACVR1B | 1.35393844 |
| 43 | EIF2AK3 | 1.32022184 |
| 44 | MST4 | 1.28237572 |
| 45 | CSF1R | 1.28139381 |
| 46 | LRRK2 | 1.24675241 |
| 47 | PIM1 | 1.23152016 |
| 48 | TGFBR1 | 1.21383343 |
| 49 | EEF2K | 1.17370851 |
| 50 | MAP3K12 | 1.15807352 |
| 51 | IKBKB | 1.15748506 |
| 52 | KDR | 1.15288928 |
| 53 | GRK1 | 1.15186786 |
| 54 | LCK | 1.14717662 |
| 55 | SRPK1 | 1.13043894 |
| 56 | PKN2 | 1.10072040 |
| 57 | NME2 | 1.09064905 |
| 58 | TSSK6 | 1.08875951 |
| 59 | JAK1 | 1.06231924 |
| 60 | PAK3 | 1.06073955 |
| 61 | PAK4 | 1.05308478 |
| 62 | ATR | 1.03845614 |
| 63 | CSK | 1.02757156 |
| 64 | LYN | 1.02690259 |
| 65 | STK4 | 0.99714239 |
| 66 | FER | 0.96055083 |
| 67 | TTK | 0.95168217 |
| 68 | MAP2K3 | 0.94020088 |
| 69 | FGFR2 | 0.92913469 |
| 70 | HCK | 0.92686467 |
| 71 | FLT3 | 0.91139209 |
| 72 | CSNK1G1 | 0.89852631 |
| 73 | GRK6 | 0.89086717 |
| 74 | SIK3 | 0.87864132 |
| 75 | PLK4 | 0.86808855 |
| 76 | PASK | 0.83796878 |
| 77 | STK16 | 0.81753675 |
| 78 | STK38L | 0.81661812 |
| 79 | FGFR3 | 0.80857453 |
| 80 | VRK1 | 0.80414217 |
| 81 | MAP3K8 | 0.80191713 |
| 82 | MARK3 | 0.79684442 |
| 83 | BMPR2 | 0.79275086 |
| 84 | CDK4 | 0.78913260 |
| 85 | SCYL2 | 0.78622362 |
| 86 | PDK2 | 0.77566675 |
| 87 | CSNK1G3 | 0.77349306 |
| 88 | TRPM7 | 0.76950172 |
| 89 | BRSK1 | 0.76923567 |
| 90 | CHUK | 0.76330945 |
| 91 | RPS6KB2 | 0.74742152 |
| 92 | NUAK1 | 0.74686429 |
| 93 | AURKB | 0.73815483 |
| 94 | CSNK1G2 | 0.73803119 |
| 95 | INSRR | 0.73506998 |
| 96 | MKNK1 | 0.73385470 |
| 97 | ADRBK2 | 0.73053674 |
| 98 | TGFBR2 | 0.72624744 |
| 99 | ERN1 | 0.71846053 |
| 100 | MAP3K10 | 0.71061960 |
| 101 | FGFR4 | 0.69333624 |
| 102 | EIF2AK2 | 0.66922417 |
| 103 | PLK1 | 0.65840370 |
| 104 | MAPK13 | 0.63026593 |
| 105 | STK24 | 0.61770108 |
| 106 | IRAK3 | 0.59984464 |
| 107 | FES | 0.59181477 |
| 108 | CCNB1 | 0.59057479 |
| 109 | STK3 | 0.57594993 |
| 110 | CDK7 | 0.56950818 |
| 111 | ERBB3 | 0.56631009 |
| 112 | EPHB1 | 0.55835192 |
| 113 | MAPKAPK2 | 0.54506738 |
| 114 | CSNK1A1L | 0.52366527 |
| 115 | NLK | 0.51369962 |
| 116 | PLK3 | 0.51045141 |
| 117 | PRKCE | 0.49983977 |
| 118 | TAOK3 | 0.48915093 |
| 119 | LIMK1 | 0.47860737 |
| 120 | CDK6 | 0.47777148 |
| 121 | MAPKAPK5 | 0.47324929 |
| 122 | MYLK | 0.47062800 |
| 123 | TRIB3 | 0.46989003 |
| 124 | NEK1 | 0.46950691 |
| 125 | GRK5 | 0.46453079 |
| 126 | ATM | 0.45899697 |
| 127 | RPS6KA6 | 0.45365460 |
| 128 | ZAK | 0.45216268 |
| 129 | CHEK1 | 0.42888077 |
| 130 | PRKCI | 0.42456591 |
| 131 | MUSK | 0.41260608 |
| 132 | MAP3K3 | 0.41115585 |
| 133 | PBK | 0.40460329 |
| 134 | MELK | 0.40340171 |
| 135 | PRKCD | 0.39978504 |
| 136 | TLK1 | 0.39518811 |
| 137 | PNCK | 0.38720877 |
| 138 | MINK1 | 0.38686068 |
| 139 | WNK4 | 0.38446138 |
| 140 | PTK2B | 0.36898409 |
| 141 | CHEK2 | 0.34776273 |
| 142 | KSR1 | 0.34172896 |
| 143 | FGFR1 | 0.31882654 |
| 144 | ERBB4 | 0.31555605 |
| 145 | IGF1R | 0.30911872 |
| 146 | ADRBK1 | 0.30328484 |
| 147 | AKT3 | 0.29010134 |
| 148 | ABL1 | 0.28170702 |
| 149 | DAPK1 | 0.28054568 |
| 150 | ROCK1 | 0.28021483 |
| 151 | * CSNK2A1 | 0.24938537 |
| 152 | PIK3CG | 0.23936028 |
| 153 | PRKCQ | 0.22084456 |
| 154 | EGFR | 0.20936984 |
| 155 | TIE1 | 0.19277805 |
| 156 | CSNK1A1 | 0.19020509 |
| 157 | GSK3A | 0.18732405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.22807073 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.63254607 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.52680132 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.43678254 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29185136 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.26100671 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.21662664 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.20998845 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.20206488 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.17284067 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.01149096 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99959451 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.94283821 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92909123 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87641682 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86901978 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83174919 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77527749 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.76946750 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.70903168 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.67726056 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67691177 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66122305 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.65954408 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65415629 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.61827893 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.58489870 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57041572 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55908551 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53714994 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51394005 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.50174732 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48020415 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47922172 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.47307202 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.47154586 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46342196 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46147499 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44113110 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43498836 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42007808 |
| 42 | Ribosome_Homo sapiens_hsa03010 | 1.40259286 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38905477 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.38626699 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37000160 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35292472 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33996694 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.31084014 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30731375 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.27809942 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.26601163 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26503023 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.25110453 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24803292 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24413882 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23913069 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21900185 |
| 58 | Asthma_Homo sapiens_hsa05310 | 1.21584506 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.21005999 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17782671 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 1.14183275 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11805769 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 1.11724976 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 1.11618299 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09955755 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09272448 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08635592 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08010857 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07254433 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07024703 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06981281 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06313693 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 1.05665930 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05525877 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 1.03359899 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03114269 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.00158019 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00039591 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96898625 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96643405 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.96621460 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96297447 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95068725 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94899681 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.93969674 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92874911 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.92727276 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92357734 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92126263 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90805056 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90520369 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87517676 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87196411 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83718616 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81100251 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.80398783 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80159315 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79774425 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78538346 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77318343 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76381826 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.76253850 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.75447496 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75143091 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74717271 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74555601 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74113682 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73812468 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72175785 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70436165 |
| 111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69784053 |
| 112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68576474 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67179659 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66442141 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66222658 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65824564 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.65363904 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.62642150 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62415526 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61889336 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60304718 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59137617 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.58257976 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56479421 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56477516 |
| 126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55740129 |
| 127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54819646 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54647961 |
| 129 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53841486 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53461208 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52165085 |
| 132 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51995991 |
| 133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51633170 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47879549 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46558704 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46167305 |
| 137 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46002014 |
| 138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45991564 |
| 139 | Purine metabolism_Homo sapiens_hsa00230 | 0.45649483 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45554970 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44445266 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44185812 |
| 143 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44019064 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43301354 |
| 145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41723796 |
| 146 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40170967 |
| 147 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40156830 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39297970 |
| 149 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39235200 |
| 150 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37455870 |
| 151 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36816746 |
| 152 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36780854 |
| 153 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36683782 |
| 154 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35298259 |
| 155 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32836728 |
| 156 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31362817 |
| 157 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30602384 |
| 158 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29948114 |

